Bloomberg News

Omega Pharma Revenue Growth Stalls, Abandons Full-Year Forecast

October 13, 2011

Oct. 13 (Bloomberg) -- Omega Pharma NV, the distributor of pharmacy products that founder Marc Coucke wants to take private, said revenue growth slowed to 1 percent in the third quarter and abandoned its full-year revenue forecast.

Revenue in the three months that ended Sept. 30 rose to 202.4 million euros from 200.3 million euros a year earlier, the Nazareth, Belgium-based company said today in a statement on its website.

To contact the editor responsible for this story: John Martens at jmartens1@bloomberg.net


Tim Cook's Reboot
LIMITED-TIME OFFER SUBSCRIBE NOW
 
blog comments powered by Disqus